We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




Two Automated Hematology Analyzers Compared for Performance

By LabMedica International staff writers
Posted on 17 Dec 2020
A complete blood count (CBC) is a highly automated laboratory test. More...
The use of highly advanced measurement methods increases the accuracy and sensitivity of the determination of individual hematological parameters, especially in the case of white blood cells differentiation.

It is important that the results of laboratory tests obtained using automated analyzers, which are currently able to perform more than 1,000 tests per day, are comparable, repeatable and reliable regardless of the analyzer used and the laboratory in which the analysis was performed.

Medical Laboratorians at the Medical University of Warsaw (Warsaw, Poland) collected 241 peripheral blood samples from adult patients. Samples of peripheral blood came from both healthy patients and those suffering from various pathologies. To perform comparative analysis of hematological parameters, complete blood count with leukocyte differentiation (CBC+ 5-DIFF) and a complete blood count (CBC) without leukocyte differentiation were used.

The complete blood count results were obtained using two automated hematology analyzers: the XN-2000 (Sysmex Corporation, Kobe, Japan) and the Yumizen H2500 (Horiba, Kyoto, Japan). The XN-2000 uses the following methods of fluorescent flow to determine all tested hematological parameters: cytometry, impedance and optical cytometry. Impedance method to count red blood cells (RBC) and platelets, and has an optical measurement channel for reticulocytes in which platelet count can also be measured. The Yumizen H2500 is a quantitative, multi-parameter, automatic hematological analyzer. It uses the double hydrodynamic focusing method, which includes measurement of polychromatic light absorbance and the impedance method.

The scientists reported that reliable leukocyte differentiation results were obtained for blood samples in which the number of white blood cells perceived using an automatic hematological analyzer was within the detection limits for both analyzers. Statistically significant differences were found for four hematological parameters: eosinophil count, immature granulocytes, mean corpuscular hemoglobin concentration (MCHC) and platelet distribution width (PDW).

The comparative study showed agreement between measurements of complete blood count parameters such as leukocyte count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (mean cell hemoglobin, MCH), red blood cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), and plateletcrit (PCT).

The authors concluded that due to the existence of variability between the results obtained from different hematology analyzers, it is recommended that patient samples be analyzed in the same laboratory using the same analyzer, in order to avoid obtaining divergent results that could be misinterpreted. Incorrect interpretation may affect further clinical management and be a source of uncertainty. The study was published in the November, 2020 issue of the journal Practical Laboratory Medicine.

Related Links:
Medical University of Warsaw
Sysmex Corporation
Horiba



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.